Post Categories
QPS will create an (LC)-ICP-MS assay to perform the critical elemental analysis in your drug development study
If you need to quantify blood zinc levels, are working on a gadolinium-based MRI contrast agent, or need to measure platinum levels in mouse…
QPS will create an (LC)-ICP-MS assay to perform the critical elemental analysis in your drug development study
March 1, 2016
If you need to quantify blood zinc levels, are working on a gadolinium-based MRI contrast agent, or need to measure platinum levels in mouse…
QPS Seen As Inspirational for Delaware
Where do you turn when you just took the package? 25% of DuPont employees (likely more on the way) got the bad news here…
QPS Seen As Inspirational for Delaware
February 25, 2016
Where do you turn when you just took the package? 25% of DuPont employees (likely more on the way) got the bad news here…
Consultation open on revised EMA Guideline on Medicines to treat Alzheimer’s Disease
The European Medicines Agency (EMA) has released a draft guideline revision on the clinical investigation of medicines for the treatment of Alzheimer’s disease and…
Consultation open on revised EMA Guideline on Medicines to treat Alzheimer’s Disease
February 15, 2016
The European Medicines Agency (EMA) has released a draft guideline revision on the clinical investigation of medicines for the treatment of Alzheimer’s disease and…
New ICP-MS Magnesium (Mg) Assays in Human Plasma and Urine added to the QPS Global Assay Database
The role of Mg in human nutrition has recently received renewed interest. Mg dietary intake has been reported to have decreased during the last…
New ICP-MS Magnesium (Mg) Assays in Human Plasma and Urine added to the QPS Global Assay Database
February 9, 2016
The role of Mg in human nutrition has recently received renewed interest. Mg dietary intake has been reported to have decreased during the last…
See QPS in London at Informa’s Early Clinical Development Conference, 23 – 24 February 2016
On February 23, Professor Zuzana Diamant, MD PhD, Director of Respiratory & Allergy Research at QPS, will talk about Biomarkers in Respiratory Drug Development…
See QPS in London at Informa’s Early Clinical Development Conference, 23 – 24 February 2016
February 5, 2016
On February 23, Professor Zuzana Diamant, MD PhD, Director of Respiratory & Allergy Research at QPS, will talk about Biomarkers in Respiratory Drug Development…
Read the QPS Whitepaper on Phase I Site Selection to support EU Registration
Making the right decision about where to conduct Phase I of a clinical trial is crucial. As long as basic EU regulatory requirements are…
Read the QPS Whitepaper on Phase I Site Selection to support EU Registration
January 6, 2016
Making the right decision about where to conduct Phase I of a clinical trial is crucial. As long as basic EU regulatory requirements are…
Wishing You a Very Happy New Year, With Some Very Cool Science
Cancer immuno therapies. Oligo therapeutics. CAR T-cell therapies. Breakthrough Antivirals. For the past 20 years, we’ve been following the path of solid science and…
Wishing You a Very Happy New Year, With Some Very Cool Science
December 16, 2015
Cancer immuno therapies. Oligo therapeutics. CAR T-cell therapies. Breakthrough Antivirals. For the past 20 years, we’ve been following the path of solid science and…
Just Out! QPS Scientist LingSing Chen Contributes Biosimilars Expertise to eBook
LingSing Chen, PhD, former VP and Global Head of Translational Medicine and Biosimilars at QPS, shares her bioanalytical expertise in a new eBook published…
Just Out! QPS Scientist LingSing Chen Contributes Biosimilars Expertise to eBook
November 16, 2015
LingSing Chen, PhD, former VP and Global Head of Translational Medicine and Biosimilars at QPS, shares her bioanalytical expertise in a new eBook published…
Growth and Goals-Our Next 10 Years: QPS 20th Anniversary Series, Part 6
The past 20 years for QPS have included countless hours of hard work, exciting change and a tireless commitment to do what is right…
Growth and Goals-Our Next 10 Years: QPS 20th Anniversary Series, Part 6
October 28, 2015
The past 20 years for QPS have included countless hours of hard work, exciting change and a tireless commitment to do what is right…
The QPS Strategy for Overcoming Business Challenges: QPS 20th Anniversary Series, Part 5
When I reflect on the past 20 years of my life, I remember both the milestones and the few challenges I encountered along the…
The QPS Strategy for Overcoming Business Challenges: QPS 20th Anniversary Series, Part 5
October 26, 2015
When I reflect on the past 20 years of my life, I remember both the milestones and the few challenges I encountered along the…
Three QPS Posters on Display at the upcoming ISSX Meeting
Come review and discuss the latest xenobiotic research with us in person. Top QPS scientists will be at the 20th North American ISSX Meeting…
Three QPS Posters on Display at the upcoming ISSX Meeting
October 15, 2015
Come review and discuss the latest xenobiotic research with us in person. Top QPS scientists will be at the 20th North American ISSX Meeting…
QPS CEO Predicts Where Industry, Company are Headed: QPS 20th Anniversary Series, Part 4
When Ben Chien, PhD, QPS Chairman, President and CEO, first started a small bioanalytical lab with just three people, he wasn’t expecting it to…
QPS CEO Predicts Where Industry, Company are Headed: QPS 20th Anniversary Series, Part 4
October 14, 2015
When Ben Chien, PhD, QPS Chairman, President and CEO, first started a small bioanalytical lab with just three people, he wasn’t expecting it to…
New Anti-Amyloid Drug Offers Cognitive Benefit for Patients with AD
A recent Phase III clinical trial found that lecanemab reduces cognitive decline in patients with early Alzheimer’s disease (AD). The findings indicate that participants…
New Anti-Amyloid Drug Offers Cognitive Benefit for Patients with AD
November 16, 2022
A recent Phase III clinical trial found that lecanemab reduces cognitive decline in patients with early Alzheimer’s disease (AD). The findings indicate that participants…
Can UV Light Replace Masks in the Fight Against COVID-19?
As the world continues to grapple with the ongoing COVID-19 pandemic, scientists continue to investigate a variety of potential treatments and prevention methods. Previous…
Can UV Light Replace Masks in the Fight Against COVID-19?
November 9, 2022
As the world continues to grapple with the ongoing COVID-19 pandemic, scientists continue to investigate a variety of potential treatments and prevention methods. Previous…
Cancer Trials Ask, What’s the Gut Got to Do With It?
There are ten times more bacterial cells in your body than human cells. They live in our noses, in our guts, and everywhere in…
Cancer Trials Ask, What’s the Gut Got to Do With It?
November 7, 2022
There are ten times more bacterial cells in your body than human cells. They live in our noses, in our guts, and everywhere in…
Are the New COVID Boosters Better Than the Old Boosters?
This fall, the FDA approved the rollout of two updated Omicron-specific COVID-19 boosters. These new COVID boosters aim to provide more protection against the…
Are the New COVID Boosters Better Than the Old Boosters?
November 2, 2022
This fall, the FDA approved the rollout of two updated Omicron-specific COVID-19 boosters. These new COVID boosters aim to provide more protection against the…
Research Reveals a Fungi-Cancer Connection, with Potential Diagnostic Implications
Like bacteria, fungal microorganisms are an important part of the human microbiome and essential to human health. Scientists studying the microbiome over the past…
Research Reveals a Fungi-Cancer Connection, with Potential Diagnostic Implications
October 31, 2022
Like bacteria, fungal microorganisms are an important part of the human microbiome and essential to human health. Scientists studying the microbiome over the past…
Can Nasal Vaccines Confer Sterilizing Immunity?
A COVID-19 vaccine that provides sterilizing immunity may be in our future – and with it, a potential light at the end of the…
Can Nasal Vaccines Confer Sterilizing Immunity?
October 26, 2022
A COVID-19 vaccine that provides sterilizing immunity may be in our future – and with it, a potential light at the end of the…
Executive Summary Biosimilars have advanced from a promising idea to a proven pathway for expanding patient access to biologic therapies and easing pressure on…
Introduction Real-world evidence (RWE) is accelerating drug development by using routinely collected patient health data, known as real-world data (RWD), to deliver insights beyond…
Introduction Researchers are developing novel, safer treatments for cancer, but bringing new oncology therapies to market is challenging. This white paper will examine the…
NEWARK, Del.–(BUSINESS WIRE)–QPS Holdings, LLC (QPS), an award-winning contract research organization (CRO) focused on bioanalysis and clinical trials announces the successful implementation of Oracle…
NEWARK, Del.—(BUSINESS WIRE)—QPS Holdings, LLC (QPS), an award-winning contract research organization (CRO) focused on bioanalytics and clinical trials, is celebrating its 30-year anniversary in…
NEWARK, Del.—(BUSINESS WIRE)—QPS India, a subsidiary of QPS Holdings, LLC (QPS), a GLP/GCP-compliant global full-service Contract Research Organization, has achieved another significant milestone by…